Physician profile
Bryan L Phillips
NPI 1629076278
$1,173.13
in general payments reported to CMS, 2019-2025
22 companies · $245 in 2025
The $245 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $21.62 · 2021: $148 · 2022: $296 · 2023: $92.58 · 2024: $168 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $182.78 | 2021-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $179.17 | 2022-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $149.27 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $99.24 | 2019-2022 | |
| Pfizer INC. | $77.94 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $68.94 | 2025 | |
| Tris Pharma INC | $55.71 | 2019-2025 | Onyda Xr |
| Adlon Therapeutics L.P. | $50.06 | 2021 | |
| Collegium Pharmaceutical, INC. | $41.69 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $39.84 | 2019-2023 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $30.33 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $30.10 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $27.70 | 2019-2025 | Relexxii |
| Ultragenyx Pharmaceutical INC. | $20.15 | 2022 | |
| Rhodes Pharmaceuticals L.P. | $19.56 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $17.68 | 2025 | Xelstrym |
| Shire North American Group INC | $16.63 | 2019 | |
| Merck Sharp & Dohme LLC | $16.04 | 2025 | |
| Kaleo, INC. | $14.37 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.08 | 2019 | |
| Intersect Ent, INC. | $12.06 | 2019 | |
| Neos Therapeutics, LP | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.